Purchase Order 75D30118P01978
Award Date 9/4/18
Potential Completion Date 3/4/19
Potential Value $125K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pearland, TX 77584, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC), an agency within the Department of Health and Human Services (HHS), to Base Pair Biotechnologies Inc. for $149,000.00. The contract is for the delivery of DNA affinity probes, which are likely to be used in biomedical research and healthcare applications. Base Pair Biotechnologies is a for-profit company that specializes in custom aptamer development services, including aptamer discovery...
- This is a $199,565.00 firm fixed price definitive contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products to the federal government. The contract was awarded on September 13, 2013 with a completion date of June 12, 2014. The contract does not have a set-aside designation. Through this contract, Base Pair...
- This is a $600,000.00 definitive contract awarded by the National Institute of Allergy and Infectious Diseases, which is part of the Department of Health and Human Services National Institutes of Health, to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products. The contract is for the "Development of Aptamer Affinity Reagents to Immune Targets in Non-Human Disease Models" and has a completion date of September 29, 2021....
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc., a privately held company specializing in oligonucleotide-based tools. The contract, valued at $87,500.00, is for the provision of laboratory equipment. Biosearch Technologies has a history of providing laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC, Department of Defense, and National...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC), a component of the Department of Health and Human Services (HHS), to Biosearch Technologies, Inc. (dba Biosearch Technologies). The $473,206.40 contract is for the provision of a SARS-COV-2 Influenza Multiplex Assay, which supports disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens such as COVID-19. Biosearch Technologies,...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $179,800.00 firm fixed price purchase order contract to Aptagen LLC, a limited liability company, for aptamer development services. The contract, which does not have a set-aside designation, is scheduled for completion on September 19, 2023. Through this contract, Aptagen LLC will provide services related to the development of aptamers, which are synthetic antibodies, including for HIV...
- This is a firm-fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Pacific Biosciences of California, Inc. for $84,000.00. The contract is for a service plan and has no set-aside designation. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) DNA/RNA sequencing technology. This contract award is likely part of Pacific Biosciences' broader work providing specialized sequencing...
- This is a $236,603.20 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC), which is part of the Department of Health and Human Services, to Biosearch Technologies, Inc. The award is for the provision of RUO (Research Use Only) oligonucleotides. Biosearch Technologies is a manufacturer of oligonucleotide-based tools, including fluorophores and dark quenchers, and has previously provided laboratory supplies such as primer probes, assay kits, PCR kits,...
- This is a $115,346.90 firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a manufacturer of nucleic acid products for the life sciences industry. The contract supports COVID-19 response efforts and is not set aside. IDT has a Federal Supply Schedule contract with the Department of Veterans Affairs to provide oligonucleotides, probes, and custom DNA/RNA synthesized...
- This is a firm fixed price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for $98,400.00. The contract, which has no set-aside designation, is for the provision of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens like influenza, COVID-19, Ebola, and Brucella....
This is a $125,000.04 firm-fixed price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products. The contract is for aptamer development services, and does not have a set-aside designation. Through prior contracts and grants, Base Pair Biotechnologies has provided research and development services related to custom aptamers, which are DNA and RNA molecules used as binding agents, to HHS agencies including the CDC and National Institutes of Health (NIH) for applications in biomedical research and healthcare.
Generated 3/23/24, 5:45 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $125.0k | 9/4/18 |